
Tenet Healthcare (THC) Stock Forecast & Price Target
Tenet Healthcare (THC) Analyst Ratings
Bulls say
Tenet Healthcare is expected to continue generating strong earnings with projected Adjusted EBITDA estimates of $4.665 billion in 2026, $4.935 billion in 2027, and $5.109 billion in 2028, surpassing its peers in the healthcare services sector. Despite potential concerns about declining HIX volumes and negative sentiment towards hospitals and healthcare services, the company's well-managed capacity to adapt and its favorable capital deployment and return posture make it significantly undervalued and a valuable opportunity for investors.
Bears say
Tenet Healthcare is facing significant headwinds in the form of a reduction in HIX enrollment, which is expected to result in a ~20% decrease in revenue. Additionally, the expiration of ACA subsidies will create a material headwind for the company. There is also a high level of uncertainty around healthcare reform and policy, which could significantly impact the company's funding environment. Although the company's financials have been strong, with a solid EBITDA margin and positive cash flow, the potential for volume pressure and uncertainties surrounding healthcare policies make for a negative outlook on Tenet Healthcare's stock.
This aggregate rating is based on analysts' research of Tenet Healthcare and is not a guaranteed prediction by Public.com or investment advice.
Tenet Healthcare (THC) Analyst Forecast & Price Prediction
Start investing in Tenet Healthcare (THC)
Order type
Buy in
Order amount
Est. shares
0 shares